Lexeo Therapeutics, Inc. · NASDAQ:LXEO
Tamayo Louis Edward sold 4,117 Lexeo Therapeutics, Inc. shares (Form 4)
Traded Aug 18, 2026 · Filed Aug 19, 2026
On Aug 18, 2026, Tamayo Louis Edward (Chief Financial Officer) sold 4,117 Lexeo Therapeutics, Inc. shares at US$4.91 for US$20,214, leaving 92,907 shares. Filed Aug 19, 2026 (Form 4).
- Sold
- 4,117 shares
- Price
- US$4.91
- Value
- US$20,214
- Holding after
- 92,907 shares
- Trading plan
- No
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 18, 2026 | Common Stock | Sale | 4,117 | US$4.91 | 92,907 | Direct |
Source
Related
- Lexeo Therapeutics, Inc.
- Tamayo Louis Edward
- Lexeo Therapeutics, Inc. shareholders
- Form 4 · Tamayo Louis Edward · Jul 1, 2026
- Schedule 13G · JPMorgan Chase & Co · Oct 13, 2026
- Form 4 · Bhalla Narinder Pal · Sep 28, 2026
- Form 4 · Otero Jose Manuel · Sep 28, 2026
- Form 4 · Townsend Richard Nolan · Sep 28, 2026
- Form 4 · Townsend Richard Nolan · Aug 19, 2026